Skip to main content
Erschienen in: Journal of Neuro-Oncology 2/2018

15.02.2018 | Clinical Study

Debulking surgery of pituitary adenoma as a strategy to facilitate definitive stereotactic radiosurgery

verfasst von: Neil Forster, Ronald Warnick, Vinita Takiar, Luke Pater, John Breneman

Erschienen in: Journal of Neuro-Oncology | Ausgabe 2/2018

Einloggen, um Zugang zu erhalten

Abstract

In patients with pituitary adenomas (PA) who are unable to undergo complete surgical resection, radiation therapy (RT), specifically stereotactic radiosurgery (SRS), results in excellent local control. However, the utility of radiosurgery may be limited by the proximity of the lesion to the optic chiasm (OC). We evaluate the efficacy of debulking surgery in increasing the PA-OC separation to convert patients into SRS candidates. From 2007 to 2015, 31 patients with PA < 2 mm from the OC underwent debulking surgery followed by RT within 2 years of resection. Coronal and sagittal T1-pre- and post-contrast sequences were used to determine PA-OC separation. Time interval between postoperative and pre-radiotherapy MRI scans and type of radiation therapy were analyzed. Functional tumor status, tumor characteristics [cavernous sinus (CS) or suprasellar (SS) involvement, chiasm/nerve encasement (NE)], and presence of ≥ 2 of these characteristics (multiple factors, MF) was also noted. Surgery converted 9 of 31 patients (29%) to SRS candidates. Median time from surgery to pre-RT planning MRI was 8 months (range 2–20). Of the 31 patients initially ineligible for SRS, 6 became eligible immediately after surgery, and another 3 were deemed eligible on follow-up. Mean PA-OC separation was 0.3 mm preoperative, 1.4 mm postoperative, and 2.1 mm at time of SRS (p = 0.002). Preoperative SS, NE, and MF involvement predicted pre-RT separation < 2 mm. Debulking surgery of unresectable pituitary tumors is a successful strategy for converting select radiosurgery-ineligible patients to radiosurgery candidates. Absence of preoperative SS, NE, and MF predicts for successful conversion.
Literatur
1.
Zurück zum Zitat Pamir MN, Kiliç T, Belirgen M, Abacioglu U, Karabekiroglu N (2007) Pituitary adenomas treated with gamma knife radiosurgery: Volumetric analysis of 100 cases with minimum 3 year follow-up. Neurosurgery 61:270 – 80CrossRefPubMed Pamir MN, Kiliç T, Belirgen M, Abacioglu U, Karabekiroglu N (2007) Pituitary adenomas treated with gamma knife radiosurgery: Volumetric analysis of 100 cases with minimum 3 year follow-up. Neurosurgery 61:270 – 80CrossRefPubMed
2.
Zurück zum Zitat Brada M, Rajan B, Traish D et al (1993) The long-term efficacy of conservative surgery and radiotherapy in the control of pituitary adenomas. Clinical Endocrinol 38:571–578CrossRef Brada M, Rajan B, Traish D et al (1993) The long-term efficacy of conservative surgery and radiotherapy in the control of pituitary adenomas. Clinical Endocrinol 38:571–578CrossRef
3.
Zurück zum Zitat Alameda C, Lucas T, Pineda E et al (2005) Experience in management of 51 non-functioning pituitary adenomas: indications for post-operative radiotherapy. J Endocrinol Investig 28:18–22CrossRef Alameda C, Lucas T, Pineda E et al (2005) Experience in management of 51 non-functioning pituitary adenomas: indications for post-operative radiotherapy. J Endocrinol Investig 28:18–22CrossRef
4.
Zurück zum Zitat Park P, Chandler WF, Barkan AL et al (2004) The role of radiation therapy after surgical resection of nonfunctional pituitary macroadenomas. Neurosurgery 55:100–107CrossRefPubMed Park P, Chandler WF, Barkan AL et al (2004) The role of radiation therapy after surgical resection of nonfunctional pituitary macroadenomas. Neurosurgery 55:100–107CrossRefPubMed
5.
Zurück zum Zitat van den Bergh AC, Van den Berg G, Schoorl MA et al (2007) Immediate postoperative radiotherapy in residual nonfunctioning pituitary adenoma: beneficial effect on local control without additional negative impact on pituitary function and life expectancy. Int J Radiat Oncol Biol Phys 67:863–869CrossRefPubMed van den Bergh AC, Van den Berg G, Schoorl MA et al (2007) Immediate postoperative radiotherapy in residual nonfunctioning pituitary adenoma: beneficial effect on local control without additional negative impact on pituitary function and life expectancy. Int J Radiat Oncol Biol Phys 67:863–869CrossRefPubMed
6.
Zurück zum Zitat Castinetti F, Nagai M, Morange I et al (2009) Long-term results of stereotactic radiosurgery in secretory pituitary adenomas. J Clin Endocrinol Metab 94:3400–3407CrossRefPubMed Castinetti F, Nagai M, Morange I et al (2009) Long-term results of stereotactic radiosurgery in secretory pituitary adenomas. J Clin Endocrinol Metab 94:3400–3407CrossRefPubMed
7.
Zurück zum Zitat Sheehan JP, Niranjan A, Sheehan JM et al (2005) Stereotactic radiosurgery for pituitary adenomas: an intermediate review of its safety, efficacy, and role in the neurosurgical treatment armamentarium. J Neurosurg 102:678–691CrossRefPubMed Sheehan JP, Niranjan A, Sheehan JM et al (2005) Stereotactic radiosurgery for pituitary adenomas: an intermediate review of its safety, efficacy, and role in the neurosurgical treatment armamentarium. J Neurosurg 102:678–691CrossRefPubMed
8.
Zurück zum Zitat Minniti G, Gilbert D, Brada M (2009) Modern techniques for pituitary radiotherapy. Rev Endocr Metab Disord 10:135–144CrossRefPubMed Minniti G, Gilbert D, Brada M (2009) Modern techniques for pituitary radiotherapy. Rev Endocr Metab Disord 10:135–144CrossRefPubMed
9.
Zurück zum Zitat Leavitt JA, Stafford SL, Link MJ, Pollock BE (2013) Long-term evaluation of radiation-induced optic neuropathy after single-fraction stereotactic radiosurgery. Int J Radiat Oncol Biol Phys 87:524–527CrossRefPubMed Leavitt JA, Stafford SL, Link MJ, Pollock BE (2013) Long-term evaluation of radiation-induced optic neuropathy after single-fraction stereotactic radiosurgery. Int J Radiat Oncol Biol Phys 87:524–527CrossRefPubMed
10.
Zurück zum Zitat Fisher C, Batke J (2013) Editorial: separation surgery. J Neurosurg Spine 18:205–206; discussion p 6CrossRefPubMed Fisher C, Batke J (2013) Editorial: separation surgery. J Neurosurg Spine 18:205–206; discussion p 6CrossRefPubMed
11.
Zurück zum Zitat Laufer I, Iorgulescu JB, Chapman T et al (2013) Local disease control for spinal metastases following “separation surgery” and adjuvant hypofractionated or high-dose single-fraction stereotactic radiosurgery: outcome analysis in 186 patients. J Neurosurg Spine 18:207–214CrossRefPubMedPubMedCentral Laufer I, Iorgulescu JB, Chapman T et al (2013) Local disease control for spinal metastases following “separation surgery” and adjuvant hypofractionated or high-dose single-fraction stereotactic radiosurgery: outcome analysis in 186 patients. J Neurosurg Spine 18:207–214CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Moulding HD, Elder JB, Lis E et al (2010) Local disease control after decompressive surgery and adjuvant high-dose single-fraction radiosurgery for spine metastases. J Neurosurg Spine 13:87–93CrossRefPubMed Moulding HD, Elder JB, Lis E et al (2010) Local disease control after decompressive surgery and adjuvant high-dose single-fraction radiosurgery for spine metastases. J Neurosurg Spine 13:87–93CrossRefPubMed
13.
Zurück zum Zitat Zierhut D, Flentje M, Adolph J, Erdmann J, Raue F, Wannenmacher M (1995) External radiotherapy of pituitary adenomas. Int J Radiat Oncol Biol Phys 33:307–314CrossRefPubMed Zierhut D, Flentje M, Adolph J, Erdmann J, Raue F, Wannenmacher M (1995) External radiotherapy of pituitary adenomas. Int J Radiat Oncol Biol Phys 33:307–314CrossRefPubMed
14.
Zurück zum Zitat McCord MW, Buatti JM, Fennell EM et al (1997) Radiotherapy for pituitary adenoma: long-term outcome and sequelae. Int J Radiat Oncol Biol Phys 39:437–444CrossRefPubMed McCord MW, Buatti JM, Fennell EM et al (1997) Radiotherapy for pituitary adenoma: long-term outcome and sequelae. Int J Radiat Oncol Biol Phys 39:437–444CrossRefPubMed
15.
Zurück zum Zitat Kim JW, Kim DG (2014) Stereotactic radiosurgery for functioning pituitary adenomas. World Neurosurg 82:58–59CrossRefPubMed Kim JW, Kim DG (2014) Stereotactic radiosurgery for functioning pituitary adenomas. World Neurosurg 82:58–59CrossRefPubMed
16.
Zurück zum Zitat Laws ER, Sheehan JP, Sheehan JM, Jagnathan J, Jane JA Jr, Oskouian R (2004) Stereotactic radiosurgery for pituitary adenomas: a review of the literature. J Neuro 69:257–272 Laws ER, Sheehan JP, Sheehan JM, Jagnathan J, Jane JA Jr, Oskouian R (2004) Stereotactic radiosurgery for pituitary adenomas: a review of the literature. J Neuro 69:257–272
17.
Zurück zum Zitat Greenman Y, Ouaknine G, Veshchev I, Reider-Groswasser I, Segev Y, Stern N (2003) Postoperative surveillance of clinically nonfunctioning pituitary macroadenomas: markers of tumour quiescence and regrowth. Clin Endocrinol 58:763–769CrossRef Greenman Y, Ouaknine G, Veshchev I, Reider-Groswasser I, Segev Y, Stern N (2003) Postoperative surveillance of clinically nonfunctioning pituitary macroadenomas: markers of tumour quiescence and regrowth. Clin Endocrinol 58:763–769CrossRef
18.
Zurück zum Zitat Mitsumori M, Shrieve DC, Alexander E, 3rd, et al (1998) Initial clinical results of LINAC-based stereotactic radiosurgery and stereotactic radiotherapy for pituitary adenomas. Int J Radiat Oncol Biol Phys 42:573–580CrossRefPubMed Mitsumori M, Shrieve DC, Alexander E, 3rd, et al (1998) Initial clinical results of LINAC-based stereotactic radiosurgery and stereotactic radiotherapy for pituitary adenomas. Int J Radiat Oncol Biol Phys 42:573–580CrossRefPubMed
19.
Zurück zum Zitat Fu P, He Y-s, Cen Y-c et al (2016) Microneurosurgery and subsequent gamma knife radiosurgery for functioning pituitary macroadenomas or giant adenomas: one institution’s experience. Clin Neurol Neurosurg 145:8–13CrossRefPubMed Fu P, He Y-s, Cen Y-c et al (2016) Microneurosurgery and subsequent gamma knife radiosurgery for functioning pituitary macroadenomas or giant adenomas: one institution’s experience. Clin Neurol Neurosurg 145:8–13CrossRefPubMed
20.
Zurück zum Zitat Pomeraniec IJ, Dallapiazza RF, Xu Z, Jane JA Jr, Sheehan JP. Early versus late Gamma Knife radiosurgery following transsphenoidal resection for nonfunctioning pituitary macroadenomas: a matched cohort study. J Neurosurg 2015:1–11 Pomeraniec IJ, Dallapiazza RF, Xu Z, Jane JA Jr, Sheehan JP. Early versus late Gamma Knife radiosurgery following transsphenoidal resection for nonfunctioning pituitary macroadenomas: a matched cohort study. J Neurosurg 2015:1–11
Metadaten
Titel
Debulking surgery of pituitary adenoma as a strategy to facilitate definitive stereotactic radiosurgery
verfasst von
Neil Forster
Ronald Warnick
Vinita Takiar
Luke Pater
John Breneman
Publikationsdatum
15.02.2018
Verlag
Springer US
Erschienen in
Journal of Neuro-Oncology / Ausgabe 2/2018
Print ISSN: 0167-594X
Elektronische ISSN: 1573-7373
DOI
https://doi.org/10.1007/s11060-018-2801-0

Weitere Artikel der Ausgabe 2/2018

Journal of Neuro-Oncology 2/2018 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.